Utility of Noncancerous Chest CT Features for Predicting Overall Survival and Noncancer Death in Patients With Stage I Lung Cancer Treated With Stereotactic Body Radiotherapy-Reference-Cited by-同舟云学术

Utility of Noncancerous Chest CT Features for Predicting Overall Survival and Noncancer Death in Patients With Stage I Lung Cancer Treated With Stereotactic Body Radiotherapy

Published:2022-10 Issue:4 Volume:219 Page:579-589
ISSN:0361-803X
Container-title:American Journal of Roentgenology
language:en
Short-container-title:American Journal of Roentgenology

Author:

Tahir Ismail¹,Marquardt J. Peter¹,Mercaldo Nathaniel D.²,Bourgouin Patrick P.¹,Wrobel Maria M.¹,Mrah Sofiane¹,Sharp Gregory C.³,Khandekar Melin J.³,Willers Henning³,Keane Florence K.³,Fintelmann Florian J.¹

Affiliation:

1. Department of Radiology, Division of Thoracic Imaging and Intervention, Massachusetts General Hospital, 55 Fruit St, Boston, MA 02114.

2. Department of Radiology, Massachusetts General Hospital, Boston, MA.

3. Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA.

Publisher

American Roentgen Ray Society

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Link

https://www.ajronline.org/doi/pdf/10.2214/AJR.22.27484

Reference48 articles.

1. Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung Cancer